These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27488901)

  • 21. High concentration formulations of recombinant human interleukin-1 receptor antagonist: I. Physical characterization.
    Alford JR; Kwok SC; Roberts JN; Wuttke DS; Kendrick BS; Carpenter JF; Randolph TW
    J Pharm Sci; 2008 Aug; 97(8):3035-50. PubMed ID: 17973297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant human interleukin-1 receptor antagonist protects mice against acute doxorubicin-induced cardiotoxicity.
    Zhu J; Zhang J; Xiang D; Zhang Z; Zhang L; Wu M; Zhu S; Zhang R; Han W
    Eur J Pharmacol; 2010 Sep; 643(2-3):247-53. PubMed ID: 20599921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do not drop: mechanical shock in vials causes cavitation, protein aggregation, and particle formation.
    Randolph TW; Schiltz E; Sederstrom D; Steinmann D; Mozziconacci O; Schöneich C; Freund E; Ricci MS; Carpenter JF; Lengsfeld CS
    J Pharm Sci; 2015 Feb; 104(2):602-11. PubMed ID: 25418950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of Nanoparticle Tracking Analysis for Quantification and Sizing of Submicron Particles of Therapeutic Proteins.
    Zhou C; Krueger AB; Barnard JG; Qi W; Carpenter JF
    J Pharm Sci; 2015 Aug; 104(8):2441-50. PubMed ID: 26017684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein Nanoparticles Promote Microparticle Formation in Intravenous Immunoglobulin Solutions During Freeze-Thawing and Agitation Stresses.
    Pardeshi NN; Zhou C; Randolph TW; Carpenter JF
    J Pharm Sci; 2018 Jul; 107(7):1852-1857. PubMed ID: 29601840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exogenous IL-1Ra attenuates intestinal mucositis induced by oxaliplatin and 5-fluorouracil through suppression of p53-dependent apoptosis.
    Wang X; Gao J; Qian L; Gao J; Zhu S; Wu M; Zhang Y; Guan W; Ye H; Yu Y; Han W
    Anticancer Drugs; 2015 Jan; 26(1):35-45. PubMed ID: 24999837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The improved dissolution and prevention of ampoule breakage attained by the introduction of pretreatment into the production process of the lyophilized formulation of recombinant human Interleukin-11 (rhIL-11).
    Hirakura Y; Kojima S; Okada A; Yokohama S; Yokota S
    Int J Pharm; 2004 Nov; 286(1-2):53-67. PubMed ID: 15501002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Freeze-dried nifedipine-lipid nanoparticles with long-term nano-dispersion stability after reconstitution.
    Ohshima H; Miyagishima A; Kurita T; Makino Y; Iwao Y; Sonobe T; Itai S
    Int J Pharm; 2009 Jul; 377(1-2):180-4. PubMed ID: 19446623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measurement of the average mass of proteins adsorbed to a nanoparticle by using a suspended microchannel resonator.
    Nejadnik MR; Jiskoot W
    J Pharm Sci; 2015 Feb; 104(2):698-704. PubMed ID: 25318413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibited nanobubble transport in a saturated porous medium: Effects of deposited colloidal particles.
    Sugimoto T; Hamamoto S; Nishimura T
    J Contam Hydrol; 2021 Oct; 242():103854. PubMed ID: 34293646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of local mobility in aggregation of beta-galactosidase lyophilized with trehalose, sucrose or stachyose.
    Yoshioka S; Miyazaki T; Aso Y; Kawanishi T
    Pharm Res; 2007 Sep; 24(9):1660-7. PubMed ID: 17404806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutaneous mast cell degranulation in rats receiving injections of recombinant human interleukin-1 receptor antagonist (rhIL-1ra) and/or its vehicle: possible clinical implications.
    Bendele A; Colloton M; Vrkljan M; Morris J; Sabados K
    J Lab Clin Med; 1995 Apr; 125(4):493-500. PubMed ID: 7706905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Embryonic implantation in mice is blocked by interleukin-1 receptor antagonist.
    Simón C; Frances A; Piquette GN; el Danasouri I; Zurawski G; Dang W; Polan ML
    Endocrinology; 1994 Feb; 134(2):521-8. PubMed ID: 8299552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanoparticle tracking analysis of particle size and concentration detection in suspensions of polymer and protein samples: Influence of experimental and data evaluation parameters.
    Gross J; Sayle S; Karow AR; Bakowsky U; Garidel P
    Eur J Pharm Biopharm; 2016 Jul; 104():30-41. PubMed ID: 27108267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of Factors Affecting Nanoparticle Tracking Analysis Results With Synthetic and Protein Nanoparticles.
    Krueger AB; Carnell P; Carpenter JF
    J Pharm Sci; 2016 Apr; 105(4):1434-43. PubMed ID: 27019960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant human interleukin-1 receptor antagonist (rhIL-1Ra) attenuates caerulein-induced chronic pancreatitis in mice.
    Shen J; Gao J; Zhang J; Xiang D; Wang X; Qian L; Shen J; Yang L; Zhu S; Wu M; Yu Y; Han W; Wang X
    Biomed Pharmacother; 2012 Mar; 66(2):83-8. PubMed ID: 22281291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanoparticle tracking analysis for the multiparameter characterization and counting of nanoparticle suspensions.
    Wright M
    Methods Mol Biol; 2012; 906():511-24. PubMed ID: 22791460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surface adsorption of recombinant human interferon-gamma in lyophilized and spray-lyophilized formulations.
    Webb SD; Golledge SL; Cleland JL; Carpenter JF; Randolph TW
    J Pharm Sci; 2002 Jun; 91(6):1474-87. PubMed ID: 12115847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spray-freeze-drying for protein powder preparation: particle characterization and a case study with trypsinogen stability.
    Sonner C; Maa YF; Lee G
    J Pharm Sci; 2002 Oct; 91(10):2122-39. PubMed ID: 12226840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-pressure studies of aggregation of recombinant human interleukin-1 receptor antagonist: thermodynamics, kinetics, and application to accelerated formulation studies.
    Seefeldt MB; Kim YS; Tolley KP; Seely J; Carpenter JF; Randolph TW
    Protein Sci; 2005 Sep; 14(9):2258-66. PubMed ID: 16081653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.